Skip to main content
Clinical Trials/NCT03745235
NCT03745235
Terminated
N/A

A Randomized Controlled Study Comparing the Influence of a Mindfulness-based Stress Reduction Program vs. Routine Management on Psychological Variables and Biological Markers Related to Immuno-inflammation Associated With Psychological Stress in Caregivers of Patients With Severe Psychiatric Disorders.

Centre Hospitalier Universitaire Dijon1 site in 1 country27 target enrollmentOctober 21, 2019

Overview

Phase
N/A
Intervention
stress reduction program based on mindfulness
Conditions
Psychiatry
Sponsor
Centre Hospitalier Universitaire Dijon
Enrollment
27
Locations
1
Primary Endpoint
measurement of inflammation by analysis of US-CRP blood levels
Status
Terminated
Last Updated
7 months ago

Overview

Brief Summary

The objective of this project is to study the influence of mindfulness meditation on psychological health (stress level, affects, emotions) and physical health parameters (rate of inflammatory markers in the blood, activity of white blood cells involved in immuno-inflammation) in caregivers of people with psychiatric disorders. This study will provide the objective scientific data required for the development of mindfulness meditation programs for psychiatric caregivers.

80 participants will be randomly assigned to one of the following two groups:

  • 40 participants in the "Mindfulness" group who will attend mindfulness meditation sessions in addition to their standard follow-up
  • 40 participants in the "Control" group who will have a standard follow-up The duration of participation is 12 months and includes 3 visits and 8 mindfulness-based meditation sessions for the "Mindfulness" group.
Registry
clinicaltrials.gov
Start Date
October 21, 2019
End Date
February 26, 2020
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patient who has given oral consent
  • adult patient
  • a caregiver of a person with a severe psychiatric disorder (schizophrenia, recurrent depression, bipolar disorder, obsessive-compulsive disorder)

Exclusion Criteria

  • protected adult
  • patient not affiliated to the national health insurance system
  • pregnant, parturient or breastfeeding woman
  • person suffering from a severe psychiatric disorder indicating a state of decompensated stress (with risk of associated biological inflammatory disturbances)
  • person suffering from an inflammatory disease (autoimmune, infectious, neoplastic, cardio-vascular pathologies

Arms & Interventions

"Mindfulness" group

Intervention: stress reduction program based on mindfulness

"Mindfulness" group

Intervention: venipunctures

Control group

Treatment as Usual

Intervention: venipunctures

"Mindfulness" group

Intervention: psychometric questionnaires

Control group

Treatment as Usual

Intervention: psychometric questionnaires

Outcomes

Primary Outcomes

measurement of inflammation by analysis of US-CRP blood levels

Time Frame: Change from Baseline US-CRP blood levels at 3 and 12 months

measurement of lymphocyte activity Th1 Th2 Th17 Treg

Time Frame: Change from Baseline lymphocytes activity Th1 Th2 Th17 Treg at 3 and 12 months

measurement of inflammation by analysis of IL-6 blood levels

Time Frame: Change from Baseline IL-6 blood levels at 3 and 12 months

Study Sites (1)

Loading locations...

Similar Trials